PE20230183A1 - Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina - Google Patents
Procesos e intermediario para la preparacion de oxetan-2-ilmetanaminaInfo
- Publication number
- PE20230183A1 PE20230183A1 PE2022001046A PE2022001046A PE20230183A1 PE 20230183 A1 PE20230183 A1 PE 20230183A1 PE 2022001046 A PE2022001046 A PE 2022001046A PE 2022001046 A PE2022001046 A PE 2022001046A PE 20230183 A1 PE20230183 A1 PE 20230183A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- formula
- oxetan
- preparation
- ilmethanamine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 6
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- QDEFNAHLCTUWAH-UHFFFAOYSA-N oxetan-2-ylmethanamine Chemical compound NCC1CCO1 QDEFNAHLCTUWAH-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/04—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D305/06—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Referido a un proceso para preparar un compuesto de formula I, o una sal del mismo que comprende las etapas: i) combinar dibencilamina y un compuesto de formula II, luego anadir una base para producir un compuesto de formula III; ii) tomar haluro de trimetilsulfuxonio en presencia de una base y combinar con una solucion del compuesto resultante de la etapa i) y calentar a mas de 40° C para producir un compuesto de formula IV; y iii) desproteger el compuesto resultante de la etapa ii). Tambien se refiere a compuestos intermediarios para la preparacion de oxetan-2-ilmetanamina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946146P | 2019-12-10 | 2019-12-10 | |
| PCT/US2020/063546 WO2021118906A1 (en) | 2019-12-10 | 2020-12-07 | Process and intermediate for the preparation of oxetan-2-ylmethanamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20230183A1 true PE20230183A1 (es) | 2023-02-01 |
Family
ID=74003942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2022001046A PE20230183A1 (es) | 2019-12-10 | 2020-12-07 | Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US12473267B2 (es) |
| EP (1) | EP4073051B1 (es) |
| JP (1) | JP7292517B2 (es) |
| KR (1) | KR102635237B1 (es) |
| CN (1) | CN114728923B (es) |
| AU (1) | AU2020401539B2 (es) |
| CL (1) | CL2022001511A1 (es) |
| CO (1) | CO2022008127A2 (es) |
| DK (1) | DK4073051T3 (es) |
| EC (1) | ECSP22046595A (es) |
| ES (1) | ES2975599T3 (es) |
| FI (1) | FI4073051T3 (es) |
| HR (1) | HRP20240343T1 (es) |
| HU (1) | HUE067201T2 (es) |
| IL (1) | IL292707B2 (es) |
| LT (1) | LT4073051T (es) |
| MA (1) | MA58104B1 (es) |
| MD (1) | MD4073051T2 (es) |
| MX (1) | MX2022006984A (es) |
| NZ (1) | NZ788612A (es) |
| PE (1) | PE20230183A1 (es) |
| PH (1) | PH12022551403A1 (es) |
| PL (1) | PL4073051T3 (es) |
| PT (1) | PT4073051T (es) |
| RS (1) | RS65238B1 (es) |
| SI (1) | SI4073051T1 (es) |
| UA (1) | UA127884C2 (es) |
| WO (1) | WO2021118906A1 (es) |
| ZA (1) | ZA202205170B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4073051T2 (ro) | 2019-12-10 | 2024-08-31 | Lilly Co Eli | Procedeu și intermediar pentru obţinerea oxetan-2-ilmetanaminei |
| CN116217522B (zh) * | 2023-02-22 | 2025-06-24 | 广东莱佛士制药技术有限公司 | Glp-1受体激动剂关键中间体的手性纯化方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208140B2 (en) * | 2003-02-19 | 2007-04-24 | Schering Aktiengesellschaft | Trimeric macrocyclic substituted benzene derivatives |
| GEP20156397B (en) | 2011-05-06 | 2015-11-10 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Process for the preparation of a rivaroxaban and intermediates formed in said process |
| US9376409B2 (en) * | 2012-05-09 | 2016-06-28 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
| EA037318B1 (ru) * | 2016-12-16 | 2021-03-11 | Пфайзер Инк. | Агонисты рецептора glp-1 и их применение |
| CA3045644C (en) | 2018-06-13 | 2024-01-16 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| PL3806855T3 (pl) | 2018-06-15 | 2023-07-24 | Pfizer Inc. | Agoniści receptora GLP-1 oraz ich zastosowania |
| CN109265389B (zh) | 2018-08-31 | 2020-08-18 | 南京富润凯德生物医药有限公司 | 2-(氨基甲基)-1-氧杂-7-氮杂螺[3.5]壬烷衍生物、中间体及其制备方法 |
| MD4073051T2 (ro) | 2019-12-10 | 2024-08-31 | Lilly Co Eli | Procedeu și intermediar pentru obţinerea oxetan-2-ilmetanaminei |
-
2020
- 2020-12-07 MD MDE20221148T patent/MD4073051T2/ro unknown
- 2020-12-07 US US17/779,447 patent/US12473267B2/en active Active
- 2020-12-07 FI FIEP20829133.6T patent/FI4073051T3/fi active
- 2020-12-07 EP EP20829133.6A patent/EP4073051B1/en active Active
- 2020-12-07 HR HRP20240343TT patent/HRP20240343T1/hr unknown
- 2020-12-07 DK DK20829133.6T patent/DK4073051T3/da active
- 2020-12-07 IL IL292707A patent/IL292707B2/en unknown
- 2020-12-07 AU AU2020401539A patent/AU2020401539B2/en active Active
- 2020-12-07 MX MX2022006984A patent/MX2022006984A/es unknown
- 2020-12-07 UA UAA202201389A patent/UA127884C2/uk unknown
- 2020-12-07 WO PCT/US2020/063546 patent/WO2021118906A1/en not_active Ceased
- 2020-12-07 SI SI202030381T patent/SI4073051T1/sl unknown
- 2020-12-07 PE PE2022001046A patent/PE20230183A1/es unknown
- 2020-12-07 KR KR1020227018626A patent/KR102635237B1/ko active Active
- 2020-12-07 PL PL20829133.6T patent/PL4073051T3/pl unknown
- 2020-12-07 HU HUE20829133A patent/HUE067201T2/hu unknown
- 2020-12-07 LT LTEPPCT/US2020/063546T patent/LT4073051T/lt unknown
- 2020-12-07 JP JP2022534655A patent/JP7292517B2/ja active Active
- 2020-12-07 MA MA58104A patent/MA58104B1/fr unknown
- 2020-12-07 NZ NZ788612A patent/NZ788612A/en unknown
- 2020-12-07 RS RS20240243A patent/RS65238B1/sr unknown
- 2020-12-07 ES ES20829133T patent/ES2975599T3/es active Active
- 2020-12-07 PT PT208291336T patent/PT4073051T/pt unknown
- 2020-12-07 PH PH1/2022/551403A patent/PH12022551403A1/en unknown
- 2020-12-07 CN CN202080082957.9A patent/CN114728923B/zh active Active
-
2022
- 2022-05-10 ZA ZA2022/05170A patent/ZA202205170B/en unknown
- 2022-06-08 CL CL2022001511A patent/CL2022001511A1/es unknown
- 2022-06-08 CO CONC2022/0008127A patent/CO2022008127A2/es unknown
- 2022-06-10 EC ECSENADI202246595A patent/ECSP22046595A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR114631A1 (es) | Métodos e intermedios para preparar compuestos de piridina | |
| CU20190086A7 (es) | Compuestos de heteroarilo bicíclicos 6-6 fusionados útiles como inhibidores de lats | |
| CL2021001098A1 (es) | Derivados de quinolina como inhibidores de la integrina alfa4beta7 | |
| MX385720B (es) | Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
| UY37428A (es) | Modulador del regulador de conductancia de transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador | |
| CL2023000154A1 (es) | Proceso para preparar tapinarof; compuestos intermediarios; solvato de tapinarof; forma cristalina y composición farmacéutica que la comprende (sol. div. 202001226). | |
| AR105292A1 (es) | Fenoxihalogenofenilamidinas y su uso como fungicidas | |
| CR20160478A (es) | Composición de control de enfermedades de plantas y método para controlar enfermedades de plantas mediante su aplicación | |
| ECSP14013239A (es) | Composiciones farmacéuticas | |
| AR133154A2 (es) | Proceso de producción de cristales de derivado de diazabiciclooctano y preparación liofilizada estable | |
| SA523451905B1 (ar) | Cdk2 مركبات بيريميدينيل-بيرازول بها استبدال كمثبطات | |
| MX2016008665A (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. | |
| EA201692341A1 (ru) | Соли дазатиниба | |
| PE20230183A1 (es) | Procesos e intermediario para la preparacion de oxetan-2-ilmetanamina | |
| AR086987A1 (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
| BR112017018580A2 (pt) | p-toluenossulfonato para inibidor de mek quinase, e forma cristalina do mesmo e método de preparação para tal | |
| AR105812A1 (es) | Métodos para la preparación de inhibidores de proteína deacetilasa | |
| CO2021009309A2 (es) | Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéuticas del mismo | |
| MX2022002941A (es) | Cristal de derivado de 1,3,5-triazina o solvato del mismo y metodo para producir el mismo. | |
| MX2020006370A (es) | Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas. | |
| AR117834A1 (es) | Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis | |
| CO2023003013A2 (es) | Proceso | |
| MX2021012544A (es) | Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de enfermedades renales. | |
| EA201990237A1 (ru) | Новые способы получения стимуляторов растворимой гуанилатциклазы | |
| MX382762B (es) | Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble. |